Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN‐RS‐T in the context of major platelet counts.

Detalles Bibliográficos
Autores principales: Divoux, Marion, Plocque, Alexia, Sevin, Margaux, Voillat, Laurent, Feugier, Pierre, Guerci‐Bresler, Agnès, Girodon, Francois, Broséus, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495870/
https://www.ncbi.nlm.nih.gov/pubmed/32983494
http://dx.doi.org/10.1002/ccr3.3026
_version_ 1783582978006319104
author Divoux, Marion
Plocque, Alexia
Sevin, Margaux
Voillat, Laurent
Feugier, Pierre
Guerci‐Bresler, Agnès
Girodon, Francois
Broséus, Julien
author_facet Divoux, Marion
Plocque, Alexia
Sevin, Margaux
Voillat, Laurent
Feugier, Pierre
Guerci‐Bresler, Agnès
Girodon, Francois
Broséus, Julien
author_sort Divoux, Marion
collection PubMed
description Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN‐RS‐T in the context of major platelet counts.
format Online
Article
Text
id pubmed-7495870
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74958702020-09-25 Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count Divoux, Marion Plocque, Alexia Sevin, Margaux Voillat, Laurent Feugier, Pierre Guerci‐Bresler, Agnès Girodon, Francois Broséus, Julien Clin Case Rep Case Reports Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN‐RS‐T in the context of major platelet counts. John Wiley and Sons Inc. 2020-06-13 /pmc/articles/PMC7495870/ /pubmed/32983494 http://dx.doi.org/10.1002/ccr3.3026 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Divoux, Marion
Plocque, Alexia
Sevin, Margaux
Voillat, Laurent
Feugier, Pierre
Guerci‐Bresler, Agnès
Girodon, Francois
Broséus, Julien
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title_full Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title_fullStr Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title_full_unstemmed Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title_short Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
title_sort efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495870/
https://www.ncbi.nlm.nih.gov/pubmed/32983494
http://dx.doi.org/10.1002/ccr3.3026
work_keys_str_mv AT divouxmarion efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT plocquealexia efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT sevinmargaux efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT voillatlaurent efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT feugierpierre efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT guercibresleragnes efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT girodonfrancois efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount
AT broseusjulien efficacyoflenalidomideinmyelodysplasticmyeloproliferativeneoplasmswithringsideroblastsandanextremeplateletcount

Ejemplares similares